Dong-hoon H. Jin

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Identification of UBE3C as an E3 ubiquitin ligase for mutant BRAF.

Identification of UBE3C as an E3 ubiquitin ligase for mutant BRAF.

Journal: Life sciences

Published: April 10, 2025

TP53 and DNA-PK as potential biomarkers for enhanced efficacy of Olaparib in colorectal cancer.

TP53 and DNA-PK as potential biomarkers for enhanced efficacy of Olaparib in colorectal cancer.

Journal: Investigational new drugs

Published: April 04, 2025

Secreted AZGP1 induced by 5-FU binds to PD-L1 and promotes apoptosis in cholangiocarcinoma.

Secreted AZGP1 induced by 5-FU binds to PD-L1 and promotes apoptosis in cholangiocarcinoma.

Journal: Molecular medicine (Cambridge, Mass.)

Published: March 15, 2025

Inactivation of VRK1 sensitizes ovarian cancer to PARP inhibition through regulating DNA-PK stability.

Inactivation of VRK1 sensitizes ovarian cancer to PARP inhibition through regulating DNA-PK stability.

Journal: Experimental cell research

Published: November 27, 2023

The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy.

The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy.

Journal: Cancer immunology research

Published: October 03, 2023

Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective PIM1 inhibitor in human colon cancer.

Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective PIM1 inhibitor in human colon cancer.

Journal: Cancer biology & therapy

Published: August 25, 2023

TCOF1 promotes the colorectal cancer progression by stabilizing β-catenin.

TCOF1 promotes the colorectal cancer progression by stabilizing β-catenin.

Journal: Medical oncology (Northwood, London, England)

Published: August 18, 2023

Discovery of Novel, Thienopyridine-Based Tyrosine Kinase Inhibitors Targeting Tumorigenic RON Splice Variants.

Discovery of Novel, Thienopyridine-Based Tyrosine Kinase Inhibitors Targeting Tumorigenic RON Splice Variants.

Journal: ACS medicinal chemistry letters

Published: May 15, 2023

Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25.

Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25.

Journal: Journal of cellular and molecular medicine

Published: March 17, 2023

Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy.

Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy.

Journal: Cell death and differentiation

Published: March 13, 2023

Effects of the purified dry extract of fermented ginseng BST204 on muscle fiber regeneration.

Effects of the purified dry extract of fermented ginseng BST204 on muscle fiber regeneration.

Journal: Biochemistry and biophysics reports

Published: February 04, 2023

DGG-300273, a novel WNT/β-catenin inhibitor, induces apoptotic cell death by activating ROS-BIM signaling in a Wnt-dependent manner in colon cancer cells.

DGG-300273, a novel WNT/β-catenin inhibitor, induces apoptotic cell death by activating ROS-BIM signaling in a Wnt-dependent manner in colon cancer cells.

Journal: Investigational new drugs

Published: July 10, 2022

Showing 1-12 of 55

Last Updated: 09/26/2026